Q5128 — Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg

What the market charges

Across 1,061 negotiated rates, the middle 80% fall between $55 and $239, with a median of $100.

What Medicare pays

Medicare allowed an average of $228 for this code, across 937,303 services billed by 470 providers. At the median, the market charges less than Medicare pays for this code — 56% less.

Where this is billed, and what it costs there

The states billing Q5128 most, by Medicare service volume, each compared against the national average of $228. Each links to the providers Mishe lists there.

  • Pennsylvania — 24 providers billed it, Medicare allowed $226 — 1% below the national average
  • California — 61 providers billed it, Medicare allowed $228 — level with the national average
  • Tennessee — 36 providers billed it, Medicare allowed $227 — level with the national average
  • Texas — 58 providers billed it, Medicare allowed $227 — level with the national average
  • New York — 31 providers billed it, Medicare allowed $227 — level with the national average
  • Florida — 48 providers billed it, Medicare allowed $232 — 2% above the national average
  • Minnesota — 18 providers billed it, Medicare allowed $228 — level with the national average
  • Arizona — 20 providers billed it, Medicare allowed $228 — level with the national average

Deploy this for your team

Every figure on this page came from published payer and Medicare data, assembled by Mishe. The same pricing, claim-editing and care-pathway intelligence runs underneath the plans Mishe operates.

Take back healthcare.